Jean-Manasse Theagene - Apr 4, 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Jean-Manasse Theagene
Stock symbol
MAIA
Transactions as of
Apr 4, 2025
Transactions value $
$0
Form type
4
Date filed
4/8/2025, 04:41 PM
Previous filing
Jan 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +20.3K $0.00 20.3K Apr 4, 2025 Common Stock 20.3K $1.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.